Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CGON will decline by -3.43% over the next 2 Weeks and hit $71.00 by Monday, August 10, 2026. In that time frame, CGON's share price is expected to range between $68.69 and $73.40.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Aug 10, 2026 | 68.69 | 71.00 | 73.40 |
| Aug 7, 2026 | 69.79 | 72.13 | 74.44 |
| Aug 6, 2026 | 68.62 | 70.90 | 73.17 |
| Aug 5, 2026 | 67.92 | 70.00 | 72.28 |
| Aug 4, 2026 | 68.21 | 70.26 | 72.25 |
| Aug 3, 2026 | 69.05 | 70.92 | 73.12 |
| Jul 31, 2026 | 70.10 | 72.05 | 74.24 |
| Jul 30, 2026 | 68.89 | 70.83 | 72.86 |
| Jul 29, 2026 | 67.68 | 69.92 | 71.94 |
| Jul 28, 2026 | 68.39 | 70.19 | 72.27 |
CGON shares fell -1.22% in Tuesday, July 28, 2026's trading session, dropping from a previous close of $73.52 to move at $72.62. The stock demonstrated notable intraday movement (see CGON's key stats for a full breakdown), fluctuating between $70.89 and $74.24, a +4.73% trading range. While recent weeks have seen some volatility, CGON has managed to secure a +1.18% gain over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 1.08M shares changing hands, 711.78K more than the previous session. This amounted to $78.47M in total market activity.
Will CGON Continue Its Upward Trend?
According to analyst ratings and projections for CGON, CG Oncology Inc. shares are anticipated to increase by +1.06%, potentially reaching $73.40 per share by August 10, 2026. Short-term technical indicators currently suggest a neutral sentiment for CGON. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the CGON stock forecast, now is a good time to buy CGON stock because its current trading price is +2.28% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on CGON covering social and institutional perspectives.
CGON Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CGON's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 55.72% to 55.91%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 55.04%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 55.26%, maintains a neutral outlook for the long term. Insights into CGON's shareholder base show how institutional investors are positioning themselves during these momentum shifts
CG Oncology Short-Term Forecasts
CGON Forecast For Next 5 Days
Our algorithm anticipates CG Oncology (CGON) stock could hit $72.52 by Aug 04, 2026. This represents a -0.13% rise from today's price, following a +1.81% change over the past five days.
CGON Forecast For Next 30 Days
Based on analysis of market trends, the outlook for CG Oncology Inc. (CGON) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $76.68, which would mean a +5.59% increase from the current price of $72.62. Projections for this period range from a high of $87.90 to a low of $64.51.
CGON Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for CG Oncology's price over the next three months point to a drop. CGON stock is expected to peak at $78.32 on Oct 12, 2026 before potentially dipping to $62.88 on Oct 28, 2026. On average, CGON is likely to trade around $71.87 in the coming 90 days.
CG Oncology Stock Forecast 2025
Based on our predictive models, CG Oncology (CGON) is expected to trade between $62.78 and $81.10 throughout 2026. This would result in an average price of $72.34, potentially offering investors a -0.39% return from current levels.
CG Oncology Inc. Monthly Forecast 2026–2027
July 2026
According to our latest forecast models, CG Oncology Inc. (CGON) is positioned to show a strong performance in July 2026. The price is predicted to move between $66.87 and $76.18, settling at an average of $71.11. This could translate to a -2.08% loss.
August 2026
Based on current market signals, CG Oncology Inc. is projected to trend august 2026. We forecast a trading range from $66.05 to $77.82, with a likely average price of $72.00. Investors could expect a potential return of -0.85%.
September 2026
Our predictive algorithms indicate CG Oncology Inc. stock may see a shift in September 2026. The expected range spans $67.05–$78.13, with an average target of $72.50. This represents a cautious outlook and a possible loss of -0.17%.
October 2026
Analyzing established trends, CG Oncology Inc. looks set to move in October 2026. Projections place the stock between $62.78 and $78.32, averaging around $70.86. This suggests a -2.42% loss from current levels.
November 2026
Market indicators suggest CG Oncology Inc. could experience notable changes during November 2026. Prices could fluctuate within $63.42 to $78.53, with a midpoint forecast of $71.50. The stock might deliver a -1.54% loss.
December 2026
Forecasting for December 2026, models estimate that CG Oncology Inc. may undergo key fluctuations. If trends hold, the stock might trade between $67.72 and $81.10, averaging $74.92. This signals a positive trajectory with potential returns around +3.17%.
January 2027
According to our latest forecast models, CG Oncology Inc. (CGON) is positioned to show a strong performance in January 2027. The price is predicted to move between $71.71 and $82.07, settling at an average of $76.69. This could translate to a +5.60% gain.
February 2027
Based on current market signals, CG Oncology Inc. is projected to trend february 2027. We forecast a trading range from $71.62 to $81.93, with a likely average price of $77.26. Investors could expect a potential return of +6.39%.
March 2027
Our predictive algorithms indicate CG Oncology Inc. stock may see a shift in March 2027. The expected range spans $67.41–$81.95, with an average target of $75.30. This represents a positive outlook and a possible gain of +3.69%.
April 2027
Analyzing established trends, CG Oncology Inc. looks set to move in April 2027. Projections place the stock between $67.87 and $82.75, averaging around $76.40. This suggests a +5.21% gain from current levels.
May 2027
Market indicators suggest CG Oncology Inc. could experience notable changes during May 2027. Prices could fluctuate within $72.43 to $85.86, with a midpoint forecast of $79.79. The stock might deliver a +9.87% gain.
June 2027
Forecasting for June 2027, models estimate that CG Oncology Inc. may undergo key fluctuations. If trends hold, the stock might trade between $75.68 and $86.71, averaging $81.32. This signals a positive trajectory with potential returns around +11.98%.
July 2027
According to our latest forecast models, CG Oncology Inc. (CGON) is positioned to show a strong performance in July 2027. The price is predicted to move between $76.46 and $87.44, settling at an average of $81.94. This could translate to a +12.83% gain.
CGON's history of dividends and stock splits also plays a role in long-term investor confidence.